rs34570566

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000497.4(CYP11B1):​c.873G>A​(p.Ala291Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0413 in 1,612,086 control chromosomes in the GnomAD database, including 3,002 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.086 ( 1078 hom., cov: 33)
Exomes 𝑓: 0.037 ( 1924 hom. )

Consequence

CYP11B1
NM_000497.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -3.62

Publications

9 publications found
Variant links:
Genes affected
CYP11B1 (HGNC:2591): (cytochrome P450 family 11 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane and is involved in the conversion of progesterone to cortisol in the adrenal cortex. Mutations in this gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
GML (HGNC:4375): (glycosylphosphatidylinositol anchored molecule like) Predicted to be involved in DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; apoptotic process; and negative regulation of cell population proliferation. Predicted to be extrinsic component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 8-142876322-C-T is Benign according to our data. Variant chr8-142876322-C-T is described in ClinVar as Benign. ClinVar VariationId is 362157.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.62 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.217 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP11B1NM_000497.4 linkc.873G>A p.Ala291Ala synonymous_variant Exon 5 of 9 ENST00000292427.10 NP_000488.3 P15538-1Q8TDD0
CYP11B1NM_001026213.1 linkc.873G>A p.Ala291Ala synonymous_variant Exon 5 of 8 NP_001021384.1 P15538-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP11B1ENST00000292427.10 linkc.873G>A p.Ala291Ala synonymous_variant Exon 5 of 9 1 NM_000497.4 ENSP00000292427.5 P15538-1

Frequencies

GnomAD3 genomes
AF:
0.0855
AC:
12894
AN:
150874
Hom.:
1073
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.221
Gnomad AMI
AF:
0.00989
Gnomad AMR
AF:
0.0455
Gnomad ASJ
AF:
0.0406
Gnomad EAS
AF:
0.0788
Gnomad SAS
AF:
0.0798
Gnomad FIN
AF:
0.0376
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0258
Gnomad OTH
AF:
0.0876
GnomAD2 exomes
AF:
0.0536
AC:
13452
AN:
251052
AF XY:
0.0514
show subpopulations
Gnomad AFR exome
AF:
0.220
Gnomad AMR exome
AF:
0.0418
Gnomad ASJ exome
AF:
0.0492
Gnomad EAS exome
AF:
0.0775
Gnomad FIN exome
AF:
0.0400
Gnomad NFE exome
AF:
0.0274
Gnomad OTH exome
AF:
0.0453
GnomAD4 exome
AF:
0.0368
AC:
53701
AN:
1461108
Hom.:
1924
Cov.:
34
AF XY:
0.0375
AC XY:
27266
AN XY:
726902
show subpopulations
African (AFR)
AF:
0.226
AC:
7440
AN:
32948
American (AMR)
AF:
0.0424
AC:
1893
AN:
44652
Ashkenazi Jewish (ASJ)
AF:
0.0516
AC:
1348
AN:
26134
East Asian (EAS)
AF:
0.0692
AC:
2747
AN:
39698
South Asian (SAS)
AF:
0.0735
AC:
6343
AN:
86252
European-Finnish (FIN)
AF:
0.0383
AC:
2044
AN:
53418
Middle Eastern (MID)
AF:
0.0963
AC:
555
AN:
5762
European-Non Finnish (NFE)
AF:
0.0254
AC:
28290
AN:
1111942
Other (OTH)
AF:
0.0504
AC:
3041
AN:
60302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
3276
6551
9827
13102
16378
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1236
2472
3708
4944
6180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0855
AC:
12916
AN:
150978
Hom.:
1078
Cov.:
33
AF XY:
0.0851
AC XY:
6279
AN XY:
73824
show subpopulations
African (AFR)
AF:
0.221
AC:
8918
AN:
40312
American (AMR)
AF:
0.0455
AC:
693
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.0406
AC:
141
AN:
3470
East Asian (EAS)
AF:
0.0790
AC:
409
AN:
5180
South Asian (SAS)
AF:
0.0803
AC:
387
AN:
4822
European-Finnish (FIN)
AF:
0.0376
AC:
399
AN:
10618
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0258
AC:
1754
AN:
68018
Other (OTH)
AF:
0.0863
AC:
182
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
566
1132
1699
2265
2831
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0638
Hom.:
311
Bravo
AF:
0.0936
Asia WGS
AF:
0.0920
AC:
317
AN:
3476
EpiCase
AF:
0.0315
EpiControl
AF:
0.0302

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Deficiency of steroid 11-beta-monooxygenase Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Apr 20, 2020
Department of Human Genetics, Laborarztpraxis Dres. Walther, Weindel und Kollegen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 12, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glucocorticoid-remediable aldosteronism Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.091
DANN
Benign
0.78
PhyloP100
-3.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34570566; hg19: chr8-143957738; COSMIC: COSV52831284; COSMIC: COSV52831284; API